Stakeholders’ Perceptions on the Implementation of the HPV Vaccine School-Entry Requirement in Puerto Rico during the COVID-19 Pandemic

Author:

Vázquez-Otero Coralia1ORCID,Medina-Laabes Diana T.2,Pérez-Guzmán Derick2ORCID,Díaz-Miranda Olga L.2,Mercado-Andino Alondra K.2,Escabí-Wojna Erika I.2ORCID,Colón-López Vivian2ORCID

Affiliation:

1. Department for Public Health, College of Health, Community and Policy, University of Texas at San Antonio, San Antonio, TX 78249, USA

2. Cancer Control and Population Sciences Division, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR 00936, USA

Abstract

This study explored the implementation of the human papillomavirus (HPV) vaccine school-entry requirement in Puerto Rico during the COVID-19 pandemic. We conducted 26 semi-structured interviews with stakeholders and community-based organizations from August 2021 to March 2022. The interview guide was developed using the 2009 Consolidated Framework for Implementation Research (CFIR). The interviews were recorded and transcribed in Spanish. Data were analyzed using applied thematic techniques. These themes included the following: (i) Intervention characteristics: Participants noted that the school-entry requirement was effective in increasing vaccination uptake prior to the pandemic. Issues with the immunization registry were noted; (ii) Outer setting: External influences, access barriers, and an increase in HPV vaccine exemptions since the implementation of the COVID-19 vaccine were discussed; (iii) Inner setting: Communication within organizations and HPV vaccination efforts improved as the pandemic progressed; (iv) Characteristics of individuals: Most agreed with the school-entry requirement, including exemptions; and (v) Process: Results showed the need to reinforce the population’s education about HPV and the vaccine. Implementation of the policy was challenging during the early stages of the pandemic due to measures enacted to stop the spread of COVID-19 and focus on the COVID-19 vaccine. Efforts to increase HPV vaccine should focus on increasing HPV vaccine education and creating collaborations.

Funder

National Cancer Institute

Comprehensive Cancer Center of the UPR

Publisher

MDPI AG

Reference44 articles.

1. Centers for Disease Control and Prevention (2024, June 04). (1 November 2021). HPV Vaccine Safety. Centers for Disease Control and Prevention, Available online: https://www.cdc.gov/hpv/hcp/vaccine-safety-data.html.

2. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015;Vichnin;Pediatr. Infect. Dis. J.,2015

3. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis;Georges;Lancet Glob. Health,2020

4. National Cancer Institute (2024, June 04). (18 October 2023). HPV and Cancer, Available online: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer.

5. World Health Organization (2024, June 04). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Available online: https://iris.who.int/bitstream/handle/10665/336583/9789240014107-eng.pdf?sequence=1.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3